Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 26, 2018
Accenture has created an open partner ecosystem designed to help independent software vendors and life sciences companies team more effectively to accelerate drug discovery efforts.
read more
Wednesday, September 18, 2019
Accenture has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes.
read more
Accenture will work with BioCelerate, a subsidiary of TransCelerate BioPharma Inc., a nonprofit focused on improving efficiencies in research and development, to develop a platform enabling its member companies to aggregate and analyze preclinical ...
read more
Friday, February 03, 2023
Accenture has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions for leading biopharma organizations across innovative areas of science including precision medicine and diagnostics, oncology, cell & ...
read more
Accelovance has signed a merger agreement with Linical, a CRO based in Asia in the fields of oncology, immunology, and neurology.
read more
Accelovance, a global contract research organization has announced the completion of enrollment and delivery of the final locked database to Heron Therapeutics for the Phase 3 trial of its 5-HT3 receptor antagonist product candidate SUSTOL®.
read more
Wednesday, February 08, 2017
Acceliant, a provider of clinical trial management solutions, has received the prestigious World Health Organization (WHO) Drug Dictionaries Medical Coding certification. The WHO Drug Dictionary is an international classification of medicines used by...
read more
Monday, December 30, 2019
Acceleron and Fulcrum have entered into a collaboration and license agreement to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space.
read more
Thursday, December 19, 2024
Accelerated Biosciences and Stemmatters announced their strategic partnership aimed at co-developing and co-marketing human induced pluripotent stem cells (“iPSC”) derived from human trophoblast stem cells (“hTSC”).
read more
Wednesday, December 19, 2018
AC Immune and WuXi Biologics announced the first steps of an exclusive strategic collaboration that covers biologics discovery, development and manufacturing.
read more
Abzena has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic inflammatory diseases.
read more
Friday, February 25, 2022
Abzena, a partner research organization for integrated services from discovery through to clinical and commercial manufacturing for biologics and bioconjugates, Alira Health, an international patient-centric and technology-enabled advisory firm whose...
read more
Monday, December 07, 2020
Abzena has announced upgrades to its chemistry GMP suites.
read more
Wednesday, January 17, 2024
Abzena has introduced the AbZelect™ and AbZelectPRO™ platforms for accelerating the generation of production cell lines used in the manufacturing of antibodies and recombinant proteins.
read more
Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for their Phase 1 clinical trial of AGX101, a first-in-class TM4SF1-directed Antibody-Drug Conjugate (ADC)...
read more